Filtered library · Archetype
Second-order beneficiary · 26 dossiers
Dossiers classified as Second-order beneficiary — 26 names, each with its thesis, kill line and next catalyst.
All 26 are dated research with a published kill line — the level named in advance that would prove the call wrong.
All dossiers SNX TD SYNNEX Corporation Medium TD SYNNEX's Hyve AI server unit is driving earnings and guidance well above forecasts while the business burns cash; the fiscal Q4 report (~January 2027) settles whether that profit turns into positive operating cash flow. AMPL Amplitude, Inc. Medium Amplitude's shares hit a new 52-week closing high of $15.29 on 8 October 2026 on a raised outlook and 21% revenue growth. The third-quarter report, expected around 4 November 2026, settles the case by testing revenue against $105.6–108.0… CAI Caris Life Sciences, Inc. Medium Caris Life Sciences is growing revenue faster than its 27–28% FY2026 guidance implies, though a steep fourth-quarter 2025 comparison narrows the room for a raise; the third-quarter report expected around 4 November 2026 shows whether… CLDT Chatham Lodging Trust Medium Chatham Lodging Trust's summer RevPAR growth of 8%–10% a month, led by its Silicon Valley hotels, runs far ahead of its 1.5%–3.0% full-year guidance. The third-quarter report, expected around 4 November 2026, shows whether earnings and the… FPS Forgent Power Solutions, Inc. Medium Forgent Power Solutions' $3.0 billion backlog and above-consensus fiscal 2027 guidance still run ahead of its shares, which closed at $39.80 on 8 October 2026, below the $49 July offering price. The mid-November first-quarter report and… FROG JFrog Ltd. Medium JFrog's 29% second-quarter revenue growth and raised $648M-$652M full-year guide keep its shares 6.5% under their 52-week closing high. The third-quarter report expected around 5 November 2026 decides whether JFrog raises that guide again… FTNT Fortinet, Inc. Medium Fortinet's firewall refresh and raised 2026 guidance hold the shares near their $191.27 52-week high, above the consensus analyst target; the 28 October 2026 third-quarter report shows whether billings and product revenue justify that… GTLB GitLab Inc. Medium GitLab's usage-based pricing for coding agents has to lift revenue above its $281–$283 million fiscal Q3 guidance, and the early-December report settles it. The shares closed at a 52-week high of $53.56 on 8 October 2026, above the $53.16… MGNI Magnite, Inc. Medium Magnite's connected-TV growth and Google's court-ordered ad-exchange remedies hold the shares within 1% of a 52-week high; the 4 November 2026 third-quarter report shows whether results confirm the raised 2026 outlook. NOW ServiceNow, Inc. Medium ServiceNow's AI products passed $1 billion in annual contract value and second-quarter subscription revenue grew 24.5%; the confirmed 28 October 2026 third-quarter report shows whether growth holds near the guided 20.5% and margins reach… S SentinelOne, Inc. Medium SentinelOne's shares hold near a 52-week high on its AI-security story while net new recurring revenue grew only 4% and executives sold into the rally; OneCon 2026 on 20 October 2026 and the early-December Q3 report decide whether results… SHOP Shopify Inc. Medium Shopify is growing revenue above 30% a year and is the checkout layer for Meta's Muse shopping agent; its third-quarter 2026 report on 3 November 2026 shows whether low-thirties revenue growth and gross profit held up. SILC Silicom Ltd Medium Silicom's networking-card revenue rose 59% in Q2 2026 and a first AI inference order adds a second growth line, with the shares now back below Needham's $60 target. The 29 October 2026 third-quarter report shows whether revenue meets the… SOPH SOPHiA GENETICS SA Medium SOPHiA GENETICS' cloud genomics platform is still growing faster than its guide, with Q2 revenue up 27% and a new Myriad prostate-cancer deal on 8 October 2026; the Q3 report, estimated for 3 November 2026, shows whether the $94–96 million… TEAM Atlassian Corporation Medium Atlassian's cloud business, up 31% in the June quarter, and new OpenAI-powered agents have carried the shares to a 52-week high; the 5 November 2026 report shows whether cloud growth meets the guided ~28.5% on $1,705–1,715 million revenue. TXN Texas Instruments Incorporated Medium Texas Instruments' analog recovery and October price increases still support the shares after a 8 October 2026 close of $288.20; the 21 October 2026 third-quarter report must land revenue inside the $5.65–6.15 billion guide to confirm it. XMTR Xometry, Inc. Medium Xometry's AI-assisted manufacturing marketplace has held its shares near a record $110.66 close on raised August guidance. The third-quarter report, expected around 4 November 2026, settles it on revenue of at least $234 million and… ZBRA Zebra Technologies Corporation Medium Zebra Technologies' raised 2026 earnings outlook has lifted the shares to within 1% of their $386.05 52-week high. The Q3 report on 3 November 2026 shows whether adjusted EPS clears the guided $4.70–$4.90 and supports a 43.3% three-month… AGM Federal Agricultural Mortgage Corporation Low Federal Agricultural Mortgage Corporation (Farmer Mac) still grows earnings from infrastructure lending, but its shares slipped below $210 after the September index addition. The early-November third-quarter report decides whether spread… IMOS ChipMOS TECHNOLOGIES INC. Low ChipMOS posted record third-quarter 2026 revenue of NT$8,400.8 million, but monthly sales were flat from August to September and its US shares already price in more. Third-quarter margins, expected around 10 November 2026, settle whether… RBRK Rubrik, Inc. Low Rubrik's 33% subscription ARR growth supports the business, but the shares already trade at the $120 consensus target. The early-December report decides whether guidance rises enough to justify more gains. RVTY Revvity, Inc. Low Revvity's case rests on AI drug-discovery customers turning a record instrument backlog into Life Sciences growth; the 3 November 2026 third-quarter report shows whether that segment returns to positive organic growth after a 37%… RXRX Recursion Pharmaceuticals, Inc. Low Recursion Pharmaceuticals' early-October short-covering spike has faded, leaving the shares priced on pipeline hope while revenue shrinks; the REC-4881 polyposis data at the 2 November 2026 CGA-IGC plenary decide whether the lead drug can… SDGR Schrodinger, Inc. Low Schrödinger's shares still trade well above the $20.80 consensus target after falling 11.3% to $28.90 on 6 October 2026, because software revenue has not confirmed 27% contract growth; the third-quarter report, estimated for about 4… TWST Twist Bioscience Corporation Low Twist Bioscience's 23% revenue growth as an AI antibody-data supplier is real, but its shares fell to a $152.05 close on 8 October 2026, 25.8% below the 5 October 2026 high, amid ARK and insider selling. The mid-November fiscal Q4 report… BE Bloom Energy Corporation Medium Bloom Energy's fuel-cell power for AI data centers and utilities keeps winning orders, but rising Treasury yields pulled the shares to $272.82 on 8 October 2026. The third-quarter report, expected around 27 October, tests whether the…